人类免疫缺陷病毒和癌症患者的克隆性血液形成
Nancy Gillis1,2, Brittney L Dickey1,3, Christelle Colin-Leitzinger1
1Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
The Journal of infectious diseases
|April 24, 2024
概括
艾滋病毒和癌症患者患有更高的克隆性血液形成 (CH),这是生物衰老的标志. CH显著恶化了这一群体的生存结果,突出了其在癌症差异中的作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 衰老研究研究 衰老研究
背景情况:
- 人类免疫缺陷病毒 (PWH) 感染者癌症死亡率的增加与预期寿命的延长和较差的结果有关.
- 先进的生物衰老被假设在PWH中驱动癌症发病率和死亡率.
- 这项研究调查了克隆性血液形成 (CH) 在PWH之间癌症差异中的作用.
研究的目的:
- 为了比较PWH中CH的患病率和临床结果,与没有艾滋病毒的人 (PWoH) 患有癌症.
- 确定CH是否是PWH癌症差异的独立风险因素.
主要方法:
- 追溯性研究比较PWH和PWoH中的CH与癌症.
- 参与者根据瘤部位,年龄,癌症序列和治疗状态进行匹配.
- 使用表观遗传甲基化钟评估生物衰老.
主要成果:
- 与类似的PWoH相比,PWH的CH患病率是CH的两倍 (23%对11%).
- 在调整患者特征后,PWH患CH的可能性是患者的四倍 (OR,4.1).
- 在PWH中,CH与显著较低的5年生存率相关 (38%与CH相比59%,没有CH).
结论:
- 与类似癌症的PWoH相比,PWH显示CH的患病率更高.
- CH可能作为一个独立的生物衰老风险因素,导致癌症PWH的存活率降低.
相关概念视频
Bone Marrow Sampling and Transplants
326
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
326
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Disorders of Leukocytes
941
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
941


